Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples
Stopped early
Conditions studied: Chlamydia Trachomatis, Gonorrhea
In brief
The objective of this study is to evaluate the performance characteristics of the AC2 assay on the Panther system using female urine specimens.
Key facts
- Study ID
- NCT02795975
- Run by
- Hologic, Inc.
- People needed
- 1766
- Starts
- 2016-06-30
- Expected to finish
- 2017-03-01
- Last updated by the study team
- 2017-03-24
Who can join
Age: 14 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- The subject is ≥14 years of age at the time of enrollment and is currently sexually active (eg, has had penile/vaginal intercourse within the past 6 months).
- For subjects under 18 years old, assent of the subject and/or parental/legal guardian permission has been obtained if required by the institutional review board (IRB).
- The subject and/or legally authorized representative is willing and able to undergo the informed consent process prior to study participation, and:
- reports symptoms consistent with a suspected STI (eg, abnormal discharge, genital itching, pain/discomfort during sexual intercourse or urination, and/or lower abdominal discomfort); or
- is asymptomatic and known to be partners with, or a contact of, a person with a confirmed or suspected STI; or
- is asymptomatic and undergoing screening evaluation for possible STIs; or
- is asymptomatic and undergoing a routine pelvic examination.
You may not qualify if…
- The subject took antibiotic medications within the last 21 days prior to collection.
- The subject already participated in the study.
- The subject has a history of illness that the PI or designee considers could interfere with or affect the conduct, results, and/or completion of the study.
Where it is running
- The University of Alabama at Birmingham — Birmingham, Alabama, United States
- Planned Parenthood of Southern New England, Inc — New Haven, Connecticut, United States
- Segal Institute for Clinical Research — Miami, Florida, United States
- Eskenazi Hospital - Indiana University School of Medicine — Indianapolis, Indiana, United States
- Clinical Trials Management, LLC — Mandeville, Louisiana, United States
- Beyer Research — Kalamazoo, Michigan, United States
- Quality Clinical Research, Inc. — Omaha, Nebraska, United States
- LabCorp — Burlington, North Carolina, United States
- University of Cincinnati — Cincinnati, Ohio, United States
- University Hospitals Case Medical Center — Cleveland, Ohio, United States
- The Ohio State University — Columbus, Ohio, United States
- Multnomah County Health Department, STD Clinic — Portland, Oregon, United States
- Geneuity — Maryville, Tennessee, United States
- Planned Parenthood Gulf Coast, Inc. — Houston, Texas, United States
- Brownstone Clinical Trials — Irving, Texas, United States
- Clinical Trials of Texas, Inc. — San Antonio, Texas, United States
- Tidewater Clinical Research, Inc. — Virginia Beach, Virginia, United States
- University of Washington Center for AIDS & STD — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.